| Dr Daniel Hansen, MD | |
|
1500 Cooper St, Fort Worth, TX 76104-2710 | |
| (682) 885-7840 | |
| (682) 885-7856 |
| Full Name | Dr Daniel Hansen |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 1500 Cooper St, Fort Worth, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760641088 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD-41845 (Iowa) | Secondary |
| 207T00000X | Neurological Surgery | Q3374 (Texas) | Primary |
| Entity Name | Cook Childrens Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750369203 PECOS PAC ID: 7719884584 Enrollment ID: O20040128000800 |
News Archive
In emerging countries such as China or Brazil, meat consumption is rising dramatically. Indeed, worldwide consumption of red meat has quadrupled since 1961. The United Nations Food and Agriculture Organization (FAO) expects increasing prosperity to lead to a doubling of global meat production by the year 2050. The question is whether our planet, with its limited farmland resources, will still be able to meet all of our needs into the future.
With a push to make hospitals and doctors more accountable for health care quality, more attention must be paid to the accuracy and reliability of measures used to evaluate caregivers, says a prominent Johns Hopkins patient safety expert.
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced positive top-line results from Study WL1001-04-03, a Phase II clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide, a novel TRPV-1 receptor modulator in the treatment of post-herpetic neuralgia (PHN).
General Practitioners in England would soon prescribe a very low calorie diet (VLCD) for patients with type 2 diabetes in England as part of an attempt to reverse the increasingly growing numbers of the disease.
Mark Lievonen, President of Sanofi Pasteur Limited, and Premier Dalton McGuinty today opened a $101 million dollar vaccine research and development facility at Sanofi Pasteur's Connaught Campus in north Toronto. This new facility establishes the Connaught Campus as the North American Centre of Excellence in analytical and bioprocessing R&D for Sanofi Pasteur globally.
› Verified 6 days ago
| Entity Name | Children's Physician Services Of South Texas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568658227 PECOS PAC ID: 3678478872 Enrollment ID: O20040324001704 |
News Archive
In emerging countries such as China or Brazil, meat consumption is rising dramatically. Indeed, worldwide consumption of red meat has quadrupled since 1961. The United Nations Food and Agriculture Organization (FAO) expects increasing prosperity to lead to a doubling of global meat production by the year 2050. The question is whether our planet, with its limited farmland resources, will still be able to meet all of our needs into the future.
With a push to make hospitals and doctors more accountable for health care quality, more attention must be paid to the accuracy and reliability of measures used to evaluate caregivers, says a prominent Johns Hopkins patient safety expert.
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced positive top-line results from Study WL1001-04-03, a Phase II clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide, a novel TRPV-1 receptor modulator in the treatment of post-herpetic neuralgia (PHN).
General Practitioners in England would soon prescribe a very low calorie diet (VLCD) for patients with type 2 diabetes in England as part of an attempt to reverse the increasingly growing numbers of the disease.
Mark Lievonen, President of Sanofi Pasteur Limited, and Premier Dalton McGuinty today opened a $101 million dollar vaccine research and development facility at Sanofi Pasteur's Connaught Campus in north Toronto. This new facility establishes the Connaught Campus as the North American Centre of Excellence in analytical and bioprocessing R&D for Sanofi Pasteur globally.
› Verified 6 days ago
| Entity Name | Texas Childrens Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861675506 PECOS PAC ID: 4385722081 Enrollment ID: O20080422000209 |
News Archive
In emerging countries such as China or Brazil, meat consumption is rising dramatically. Indeed, worldwide consumption of red meat has quadrupled since 1961. The United Nations Food and Agriculture Organization (FAO) expects increasing prosperity to lead to a doubling of global meat production by the year 2050. The question is whether our planet, with its limited farmland resources, will still be able to meet all of our needs into the future.
With a push to make hospitals and doctors more accountable for health care quality, more attention must be paid to the accuracy and reliability of measures used to evaluate caregivers, says a prominent Johns Hopkins patient safety expert.
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced positive top-line results from Study WL1001-04-03, a Phase II clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide, a novel TRPV-1 receptor modulator in the treatment of post-herpetic neuralgia (PHN).
General Practitioners in England would soon prescribe a very low calorie diet (VLCD) for patients with type 2 diabetes in England as part of an attempt to reverse the increasingly growing numbers of the disease.
Mark Lievonen, President of Sanofi Pasteur Limited, and Premier Dalton McGuinty today opened a $101 million dollar vaccine research and development facility at Sanofi Pasteur's Connaught Campus in north Toronto. This new facility establishes the Connaught Campus as the North American Centre of Excellence in analytical and bioprocessing R&D for Sanofi Pasteur globally.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Hansen, MD Po Box 733784, Dallas, TX 75373-3784 Ph: (682) 885-1855 | Dr Daniel Hansen, MD 1500 Cooper St, Fort Worth, TX 76104-2710 Ph: (682) 885-7840 |
News Archive
In emerging countries such as China or Brazil, meat consumption is rising dramatically. Indeed, worldwide consumption of red meat has quadrupled since 1961. The United Nations Food and Agriculture Organization (FAO) expects increasing prosperity to lead to a doubling of global meat production by the year 2050. The question is whether our planet, with its limited farmland resources, will still be able to meet all of our needs into the future.
With a push to make hospitals and doctors more accountable for health care quality, more attention must be paid to the accuracy and reliability of measures used to evaluate caregivers, says a prominent Johns Hopkins patient safety expert.
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced positive top-line results from Study WL1001-04-03, a Phase II clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide, a novel TRPV-1 receptor modulator in the treatment of post-herpetic neuralgia (PHN).
General Practitioners in England would soon prescribe a very low calorie diet (VLCD) for patients with type 2 diabetes in England as part of an attempt to reverse the increasingly growing numbers of the disease.
Mark Lievonen, President of Sanofi Pasteur Limited, and Premier Dalton McGuinty today opened a $101 million dollar vaccine research and development facility at Sanofi Pasteur's Connaught Campus in north Toronto. This new facility establishes the Connaught Campus as the North American Centre of Excellence in analytical and bioprocessing R&D for Sanofi Pasteur globally.
› Verified 6 days ago
Anita Praful Bhansali, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 5th Ave Ste 500, Fort Worth, TX 76104 Phone: 817-250-4280 Fax: 817-250-4281 | |
Abdolreza Siadati, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Mistletoe Blvd, Suite 200, Fort Worth, TX 76104 Phone: 817-878-5333 Fax: 817-878-5334 | |
Gregory Alan Ward, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 909 9th Ave, Suite 201, Fort Worth, TX 76104 Phone: 817-870-5094 Fax: 817-885-7352 | |
Philip C Bechtel, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1900 Mistletoe Blvd, Suite 200, Fort Worth, TX 76104 Phone: 817-878-5333 Fax: 817-878-5334 | |
Yves J. Meyer, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1325 Pennsylvania Ave Ste 890, Fort Worth, TX 76104 Phone: 817-820-4280 Fax: 817-820-4281 | |
Dr. Atif Haque, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 8th Ave Ste A1131, Fort Worth, TX 76104 Phone: 817-912-9250 | |
Adrian Timothy Harvey, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 5th Ave Ste 500, Fort Worth, TX 76104 Phone: 817-250-4280 Fax: 817-250-4281 |